New director today (3 September 2015) announced by the National Institute for Biological Standards and Control (NIBSC).
The National Institute for Biological Standards and Control (NIBSC) is today announcing the appointment of a new director, following the announcement of the forthcoming retirement of current Director Dr Stephen Inglis who has led the institute for the past 14 years.
Dr Christian K Schneider is currently head of the medical division of the Danish Health and Medicines Authority and will begin working at NIBSC in January 2016.
Dr Ian Hudson, Chief Executive of MHRA said:
I am delighted to announce that Christian K Schneider will join the institute on 1 January 2016 as director designate, formally taking over as director on 1 April 2016.
Christian qualified in medicine and previously worked at the Max Planck Institute for Neurobiology, the Paul Ehrlich Institute in Germany and is currently the Medical Head of Division, Medicines Licensing and Availability of the Danish Health and Medicines Authority.
Christian has a strong scientific background with an extensive publication record and a wealth of experience with a broad range of biological products.
He is a former chair of the Committee for Advanced Therapies and continues to chair the Committee for Medicinal Products for Human Use (CHMP) Working Party on Similar Biological Medicinal Products at the European Medicines Agency (EMA) as well as being a former CHMP member.
I would like to take this opportunity to personally thank Stephen for his leadership of NIBSC, which has gone from strength to strength under his directorship, continuing to lead the world in biological standards, making a very significant contribution to public health throughout the world through its work on biological medicines.
The National Institute for Biological Standards and Control (NIBSC) is a world leader in assuring the quality of biological medicines through product testing, developing standards and reference materials and carrying out applied research. NIBSC is a centre of the Medicines and Healthcare products Regulatory Agency which also includes CPRD and MHRA. The Medicines and Healthcare products Regulatory Agency is an executive agency of the Department of Health.
151 Buckingham Palace Road
During office hours: 020 3080 7651 (08:30 - 17:00)
Out of office hours: 07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Published: 3 September 2015